IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $146,832 | -78.8% | 13,800 | -75.0% | 0.02% | -84.5% |
Q1 2022 | $693,000 | +225.4% | 55,100 | +161.1% | 0.10% | +123.9% |
Q1 2020 | $213,000 | +36.5% | 21,100 | +80.3% | 0.05% | +70.4% |
Q4 2019 | $156,000 | -16.6% | 11,700 | -18.2% | 0.03% | -75.9% |
Q2 2016 | $187,000 | – | 14,311 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $172,422,800 | 22.05% |
13D Management LLC | 533,562 | $5,613,073 | 2.85% |
Quantedge Capital Pte Ltd | 541,200 | $5,693,424 | 2.22% |
Price Jennifer C. | 520,000 | $5,470,400 | 1.74% |
Tamarack Advisers, LP | 210,000 | $2,209,200 | 0.81% |
Intrinsic Value Partners, LLC | 51,605 | $542,885 | 0.73% |
Brown Capital Management | 3,933,933 | $41,384,975 | 0.62% |
Old West Investment Management, LLC | 75,219 | $791,303 | 0.43% |
EMC Capital Management | 43,315 | $456 | 0.38% |
Hillsdale Investment Management Inc. | 420,617 | $4,424,891 | 0.38% |